GABRB2 and neoplasm: Because of GABRB2’s upregulation in over a third of ACC tumors and its positive association with patient clinical outcome, as well as the expression of other GABAA receptor subunit-encoding genes, we examined whether the transcript complement of each tumor supports the expression of heteropentameric GABAA receptors.